MedTrace Logo

Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)

NCT00951028 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2013-06-18

No results posted yet for this study

Summary

This study will test a therapy for both helping people adhere to their HIV medication regimens and treating them for depression.

Conditions

Interventions

BEHAVIORAL

Cognitive behavioral therapy (CBT) for adherence and depression (CBT-AD)

12 therapy sessions delivered over 4 months, using cognitive behavioral strategies to target depressive symptoms and adherence to HIV medications

BEHAVIORAL

Life-steps adherence treatment

Single-session adherence treatment that targets informational, problem solving, and cognitive-behavioral steps geared toward improving HIV medication adherence and self-management

BEHAVIORAL

Information and supportive psychotherapy (ISP) for adherence and depression (ISP-AD)

12 therapy sessions delivered over 4 months, providing education and support that target depressive symptoms and adherence to HIV medications.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Steven A. Safren, PhD · Partners HealthCare

  • C. Andres Bedoya, PhD · Partners HealthCare

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00951028 on ClinicalTrials.gov